Certainly dependent on the outcome of their trial a negative outcome would have a short term material effect. However, a positive outcome in theory may have an effect but practically speaking it took Neuren nearly 18 months between release of phase III data to launch date. So before any impact, we will be well established and advanced, at least 18 to 24 months down the track. A time period that will likely see significant company changing events occur.
That’s also assuming the FDA accepts that their positive results are indeed positive results
Certainly dependent on the outcome of their trial a negative...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.079B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.82M | 1.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1827 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |